KellyOCG, a global workforce solutions provider, was ranked No. 1 in healthcare Recruitment Process Outsourcing (RPO) and No. 2 overall in HRO Today's 2026 Baker's Dozen Customer Satisfaction Ratings. This marks an improvement from their 2025 rankings, reflecting strong client satisfaction based on service quality, deal size, and service breadth. KellyOCG supports clients in over 70 countries with advanced technology and consulting services, aiming to enhance talent acquisition outcomes. The recognition highlights KellyOCG's leadership and innovation in the RPO market, positioning them as a top choice for enterprise and healthcare recruitment solutions.
KellyOCG's recent ranking as No. 1 in healthcare RPO and No. 2 overall in HRO Today's 2026 Baker's Dozen highlights its leadership in recruitment process outsourcing. For readers following the health sector, here is Pluang's market snapshot as of Oct 13, 2026 20:12 WIB: out of 128 priced US health stocks, 75 rose and 49 fell. Notable movers include Twist Bioscience Corp (TWST) at USD 145.68 with a 1-day change of -4.07% and an 84% buy order activity, BioNTech SE (BNTX) at USD 92.15 down 3.85%, and Moderna, Inc. (MRNA) at USD 207.34 down 2.99% with a 55% buy order activity.
Existing-home sales in the U.S. increased by 1.5% month-over-month in September but declined 2.2% compared to the previous year, according to the National Association of Realtors. Sales rose in the South and West regions but fell in the Northeast and...
Columbus Marketing Experts, a digital marketing agency in Hilliard, Ohio, is expanding its local SEO services across Columbus to help service businesses improve their visibility on Google Search and Google Maps. The expansion aims to enhance local di...
Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...
Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...
Nvidia CEO Jensen Huang has reaffirmed his forecast that global spending on AI infrastructure will grow significantly, reaching between $3 trillion and $4 trillion by 2030. This projection highlights the massive potential and ongoing investment in AI...
